What is Tennr?
Tennr operates as an AI-powered automation platform specifically engineered to address the administrative burden inherent in healthcare organizations. At the core of its technology is the proprietary RaeLM vision language model, which enables the system to ingest, interpret, and process complex medical documentation. This includes patient intake forms, insurance claims, and referral letters, which are traditionally handled through labor-intensive manual workflows.
By automating these critical touchpoints, Tennr minimizes human error and significantly accelerates operational throughput. This allows healthcare providers to shift their focus from back-office paperwork to direct patient care, effectively bridging the gap between legacy administrative processes and modern digital efficiency. The platform's ability to integrate into existing clinical workflows makes it a vital tool for organizations seeking to optimize their operational performance.
How much funding has Tennr raised?
Tennr has raised a total of $156M across 3 funding rounds:
Series A
$18M
Series B
$37M
Series C
$101M
Series A (2024): $18M with participation from Foundation Capital, Andreessen Horowitz, and The New Normal Fund
Series B (2024): $37M led by Lightspeed Ventures and Andreessen Horowitz
Series C (2025): $101M supported by Frank Slootman, Foundation Capital, Lightspeed, ICONIQ Capital, and Andreessen Horowitz
Key Investors in Tennr
Frank Slootman
A renowned executive and leader known for driving high-growth performance in enterprise software, providing strategic guidance on operational intensity and business scaling.
Foundation Capital
A venture capital firm that partners with bold founders to build category-defining technology companies, offering deep operational expertise from early stages through long-term growth.
Lightspeed
A global technology firm specializing in cloud-based software and payment solutions, focused on enabling businesses to manage operations and scale effectively.
What's next for Tennr?
With this latest infusion of capital, Tennr is poised to scale its operations and deepen its technological moat. The strategic focus will likely center on expanding the capabilities of the RaeLM model to handle increasingly complex medical data sets and broadening its market reach to larger enterprise healthcare systems. As the company matures, the emphasis will shift toward sustaining high-growth metrics while maintaining the operational intensity required to dominate the healthcare automation vertical.
The involvement of seasoned investors suggests a clear path toward long-term value creation. Future initiatives will likely include aggressive talent acquisition, further refinement of its document processing engine, and the potential for strategic partnerships that could solidify its position as an essential infrastructure layer for modern medical practices.
